Andrew Kamholz has worked in microfluidics since 1994. After earning a B.S. in biomedical engineering at Johns Hopkins University in 1996, Andrew joined Paul Yager’s microfluidics group at the University of Washington. There, while earning his Ph.D. in bioengineering, he studied microfabrication, optics, diffusion, and various microfluidic assay systems. After graduating in 2001, he worked for MesoSystems Technology (now part of FLIR® Systems, Inc) and most recently served as Director of Advanced Development with the Boston division of Tecan, which commercialized the LabCD®, a centrifugal microfluidic assay platform. He founded Edge Embossing in 2005.
In addition, Andrew is a registered patent agent, authorized to act before the US Patent & Trademark office in patent cases.
Andrew is a co-inventor on more than a dozen issued US and foreign patents, a co-inventor on more than 50 published patent applications, and has authored more than a dozen peer-reviewed scientific articles.